Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based study

…, S Thiel, K Grossmann, N Wohlwend… - Clinical Chemistry and …, 2020 - degruyter.com
Objectives The sensitivity of molecular and serological methods for COVID-19 testing in an
epidemiological setting is not well described. The aim of the study was to determine the …

[HTML][HTML] Quantification of the spread of SARS-CoV-2 variant B. 1.1. 7 in Switzerland

…, C Noppen, L Risch, M Risch, N Wohlwend… - Epidemics, 2021 - Elsevier
Background In December 2020, the United Kingdom (UK) reported a SARS-CoV-2 Variant
of Concern (VoC) which is now named B.1.1.7. Based on initial data from the UK and later …

SARS-CoV-2 N501Y introductions and transmissions in Switzerland from beginning of October 2020 to February 2021—implementation of Swiss-wide diagnostic …

…, CMJA Metzger, J Sieber, M Bel, N Wohlwend… - Microorganisms, 2021 - mdpi.com
The rapid spread of the SARS-CoV-2 lineages B.1.1.7 (N501Y.V1) throughout the UK, B.1.351
(N501Y.V2) in South Africa, and P.1 (B.1.1.28.1; N501Y.V3) in Brazil has led to the …

Characterization of a pan-immunoglobulin assay quantifying antibodies directed against the receptor binding domain of the SARS-CoV-2 S1-subunit of the spike …

…, M Pichler, K Grossmann, N Wohlwend… - Journal of clinical …, 2020 - mdpi.com
Pan-immunoglobulin assays can simultaneously detect IgG, IgM and IgA directed against
the receptor binding domain (RBD) of the S1 subunit of the spike protein (S) of severe acute …

The technical and biological reproducibility of matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) based typing: employment …

M Oberle, N Wohlwend, D Jonas, FP Maurer, G Jost… - PloS one, 2016 - journals.plos.org
Background The technical, biological, and inter-center reproducibility of matrix-assisted laser
desorption ionization-time of flight mass spectrometry (MALDI TOF MS) typing data has not …

Investigation of the use of a sensor bracelet for the presymptomatic detection of changes in physiological parameters related to COVID-19: An interim analysis of a …

…, OC Weideli, M Kovac, F Pereira, N Wohlwend… - BMJ open, 2022 - bmjopen.bmj.com
Objectives We investigated machinelearningbased identification of presymptomatic COVID-19
and detection of infection-related changes in physiology using a wearable device. Design …

[HTML][HTML] Characteristics of three different chemiluminescence assays for testing for SARS-CoV-2 antibodies

…, SL Thiel, K Grossmann, S Nigg, N Wohlwend… - Disease …, 2021 - hindawi.com
Several tests based on chemiluminescence immunoassay techniques have become available
to test for SARS-CoV-2 antibodies. There is currently insufficient data on serology assay …

Sustained SARS-CoV-2 nucleocapsid antibody levels in nonsevere COVID-19: a population-based study

…, S Thiel, K Jüngert, M Pichler, N Wohlwend… - Clinical Chemistry and …, 2021 - degruyter.com
Antibodies against the receptor-binding domain (RBD) of SARS-CoV-2 spike (S) protein are
known to decay rapidly in patients with mild COVID-19 [1]. Titers of these antibodies have a …

Third-generation-cephalosporin-resistant Klebsiella pneumoniae isolates from humans and companion animals in Switzerland: spread of a DHA-producing sequence …

N Wohlwend, A Endimiani, T Francey… - Antimicrobial agents …, 2015 - Am Soc Microbiol
… (This study was conducted by Nadia Wohlwend in partial fulfillment of the requirements for
an MS thesis from the Molecular Life Sciences program of the Science Faculty, University of …

[HTML][HTML] Temporal course of SARS-CoV-2 antibody positivity in patients with COVID-19 following the first clinical presentation

…, S Thiel, K Grossmann, N Wohlwend… - BioMed research …, 2020 - hindawi.com
Knowledge of the sensitivities of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
antibody tests beyond 35 days after the clinical onset of COVID-19 is insufficient. We …